Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras association domain-containing protein 7 (RASSF7) is a member of the N-terminal Ras association domain family, distinct from classical RASSF proteins, and acts as a centrosome-associated protein essential for mitotic spindle formation and progression through mitosis[1][2][3][4]. RASSF7 is widely expressed in embryonic and adult tissues, localizes to the centrosome in a microtubule-dependent manner, and is a key regulator of microtubule growth and dynamics during cell division[1][2][4]. Knockdown or loss of RASSF7 disrupts spindle formation, leads to mitotic arrest, nuclear breakdown, apoptosis, and defects in chromosomal congression; it has been implicated in the maintenance of genomic stability, with dysregulation observed in certain cancers[1][2][3][4]. Key points from recent studies: - **Role in mitosis:** RASSF7 is required for proper spindle formation and mitotic progression; its depletion leads to mitotic arrest, failed division, and aneuploidy[1][2][3][4]. - **Microtubule regulation:** It directly affects centrosome function and microtubule regrowth, influencing the structural integrity of the mitotic spindle[4]. - **Cancer association:** RASSF7 is upregulated in a variety of cancer types, and aberrant expression may promote or be associated with oncogenic processes[4]. - **Mechanistic detail:** Its functional significance centers on its interaction with microtubules and involucration in centrosome- and cytoskeleton-dependent mitotic events; its deficiency impairs Aurora B activation and chromosomal alignment[4]. No current drugs or drug mechanisms are established for RASSF7, and it is not a recognized therapeutic target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras association domain-containing protein 7 (RASSF7).